{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T21:40:01Z","timestamp":1791841201758,"version":"4.3.4"},"reference-count":147,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.cyto.2014.11.020","type":"journal-article","created":{"date-parts":[[2015,1,14]],"date-time":"2015-01-14T06:15:50Z","timestamp":1421216150000},"page":"54-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":101,"title":["Involvement of the IL-23\/IL-17 axis and the Th17\/Treg balance in the pathogenesis and control of autoimmune arthritis"],"prefix":"10.1016","volume":"74","author":[{"given":"Brian","family":"Astry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivaprasad H.","family":"Venkatesha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal D.","family":"Moudgil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2014.11.020_b0005","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.4049\/jimmunol.136.7.2348","article-title":"Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins","volume":"136","author":"Mosmann","year":"1986","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2014.11.020_b0010","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.iy.07.040189.001045","article-title":"TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties","volume":"7","author":"Mosmann","year":"1989","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.cyto.2014.11.020_b0015","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/0167-5699(96)80606-2","article-title":"The expanding universe of T-cell subsets: Th1, Th2 and more","volume":"17","author":"Mosmann","year":"1996","journal-title":"Immunol Today"},{"key":"10.1016\/j.cyto.2014.11.020_b0020","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1016\/S0041-1345(98)00659-9","article-title":"Th1\/Th2 balance in human disease","volume":"30","author":"D\u2019Elios","year":"1998","journal-title":"Transpl Proc"},{"key":"10.1016\/j.cyto.2014.11.020_b0025","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/nature01355","article-title":"Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain","volume":"421","author":"Cua","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.cyto.2014.11.020_b0030","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1084\/jem.20030896","article-title":"Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation","volume":"198","author":"Murphy","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.cyto.2014.11.020_b0035","doi-asserted-by":"crossref","first-page":"5948","DOI":"10.4049\/jimmunol.181.9.5948","article-title":"IL-23 promotes maintenance but not commitment to the Th17 lineage","volume":"181","author":"Stritesky","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2014.11.020_b0040","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.cyto.2014.11.020_b0045","first-page":"585","article-title":"The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing","volume":"14","author":"Gaffen","year":"2014","journal-title":"Nat Rev"},{"key":"10.1016\/j.cyto.2014.11.020_b0050","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00281-009-0189-9","article-title":"Th17 cytokines and arthritis","volume":"32","author":"Lubberts","year":"2010","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.cyto.2014.11.020_b0055","doi-asserted-by":"crossref","first-page":"540","DOI":"10.4049\/jimmunol.1400931","article-title":"IL-17 promotes murine lupus","volume":"193","author":"Amarilyo","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2014.11.020_b0060","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/ni.2002","article-title":"RORgammat+ innate lymphoid cells regulate intestinal homeostasis by integrating negative signals from the symbiotic microbiota","volume":"12","author":"Sawa","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/j.cyto.2014.11.020_b0065","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/ni.1783","article-title":"Thymic self-reactivity selects natural interleukin 17-producing T cells that can regulate peripheral inflammation","volume":"10","author":"Marks","year":"2009","journal-title":"Nat Immunol"},{"key":"10.1016\/j.cyto.2014.11.020_b0070","first-page":"145","article-title":"Innate lymphoid cells\u2013a proposal for uniform nomenclature","volume":"13","author":"Spits","year":"2013","journal-title":"Nat Rev"},{"key":"10.1016\/j.cyto.2014.11.020_b0075","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/jid.2013.477","article-title":"Characterization of innate lymphoid cells in human skin and blood demonstrates increase of NKp44+ ILC3 in psoriasis","volume":"134","author":"Villanova","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.cyto.2014.11.020_b0080","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.cyto.2013.07.022","article-title":"IL-17 family: cytokines, receptors and signaling","volume":"64","author":"Gu","year":"2013","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2014.11.020_b0085","doi-asserted-by":"crossref","first-page":"36","DOI":"10.4049\/jimmunol.177.1.36","article-title":"Cutting edge: interleukin 17 signals through a heteromeric receptor complex","volume":"177","author":"Toy","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2014.11.020_b0090","doi-asserted-by":"crossref","first-page":"5337","DOI":"10.4049\/jimmunol.162.9.5337","article-title":"NF-kappa B-inducing kinase is a common mediator of IL-17-, TNF-alpha-, and IL-1 beta-induced chemokine promoter activation in intestinal epithelial cells","volume":"162","author":"Awane","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2014.11.020_b0095","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1084\/jem.191.7.1233","article-title":"Requirement of tumor necrosis factor receptor-associated factor (TRAF)6 in interleukin 17 signal transduction","volume":"191","author":"Schwandner","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.cyto.2014.11.020_b0100","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1600-065X.2008.00699.x","article-title":"The roles of IL-17A in inflammatory immune responses and host defense against pathogens","volume":"226","author":"Iwakura","year":"2008","journal-title":"Immunol Rev"},{"key":"10.1016\/j.cyto.2014.11.020_b0105","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1749-6632.2009.05133.x","article-title":"Th1 and Th17 cells: adversaries and collaborators","volume":"1183","author":"Damsker","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.cyto.2014.11.020_b0110","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/art.22453","article-title":"Interferon-gamma regulates susceptibility to collagen-induced arthritis through suppression of interleukin-17","volume":"56","author":"Chu","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cyto.2014.11.020_b0115","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1074\/jbc.M110.187013","article-title":"Interleukin-27 and interferon-gamma are involved in regulation of autoimmune arthritis","volume":"286","author":"Rajaiah","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cyto.2014.11.020_b0120","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1002\/eji.201142209","article-title":"Cooperation of Th1 and Th17 cells determines transition from autoimmune myocarditis to dilated cardiomyopathy","volume":"42","author":"Nindl","year":"2012","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.cyto.2014.11.020_b0125","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1084\/jem.20061775","article-title":"Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction","volume":"203","author":"Sato","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.cyto.2014.11.020_b0130","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/art.20885","article-title":"Induction of cartilage damage by overexpression of T cell interleukin-17A in experimental arthritis in mice deficient in interleukin-1","volume":"52","author":"Koenders","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cyto.2014.11.020_b0135","doi-asserted-by":"crossref","first-page":"518094","DOI":"10.1155\/2013\/518094","article-title":"Mediators of inflammation-induced bone damage in arthritis and their control by herbal products","volume":"2013","author":"Nanjundaiah","year":"2013","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.cyto.2014.11.020_b0140","doi-asserted-by":"crossref","first-page":"15138","DOI":"10.1074\/jbc.M111.226365","article-title":"Celastrus-derived Celastrol suppresses autoimmune arthritis by modulating antigen-induced cellular and humoral effector responses","volume":"286","author":"Venkatesha","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cyto.2014.11.020_b0145","first-page":"85","article-title":"High IL-23 level is a marker of disease activity in rheumatoid arthritis","volume":"20","author":"Abu Al","year":"2013","journal-title":"Egypt J Immunol\/Egypt Assoc Immunol"},{"key":"10.1016\/j.cyto.2014.11.020_b0150","doi-asserted-by":"crossref","first-page":"850","DOI":"10.3760\/cma.j.issn.0366-6999.20113093","article-title":"Increased interleukin-23 is associated with increased disease activity in patients with rheumatoid arthritis","volume":"126","author":"Guo","year":"2013","journal-title":"Chin Med J"},{"key":"10.1016\/j.cyto.2014.11.020_b0155","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s10067-011-1737-y","article-title":"Serum and synovial fluid levels of interleukin-17 in correlation with disease activity in patients with RA","volume":"30","author":"Metawi","year":"2011","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.cyto.2014.11.020_b0160","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.coi.2007.07.020","article-title":"Th17: the third member of the effector T cell trilogy","volume":"19","author":"Bettelli","year":"2007","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.cyto.2014.11.020_b0165","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.immuni.2009.08.001","article-title":"Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity","volume":"31","author":"Sutton","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2014.11.020_b0170","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1042\/CS20110496","article-title":"IL-17\/IL-17 receptor system in autoimmune disease: mechanisms and therapeutic potential","volume":"122","author":"Zhu","year":"2012","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.cyto.2014.11.020_b0175","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.cell.2006.07.035","article-title":"The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells","volume":"126","author":"Ivanov","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.cyto.2014.11.020_b0180","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nature05970","article-title":"IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells","volume":"448","author":"Korn","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.cyto.2014.11.020_b0185","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/ni1496","article-title":"Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells","volume":"8","author":"Acosta-Rodriguez","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.cyto.2014.11.020_b0190","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/ni1497","article-title":"Development, cytokine profile and function of human interleukin 17-producing helper T cells","volume":"8","author":"Wilson","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.cyto.2014.11.020_b0195","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature07021","article-title":"IL-21 and TGF-beta are required for differentiation of human T(H)17 cells","volume":"454","author":"Yang","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.cyto.2014.11.020_b0200","doi-asserted-by":"crossref","first-page":"5332","DOI":"10.4049\/jimmunol.165.9.5332","article-title":"Up-regulation of IL-17 is associated with bioactive IL-8 expression in Helicobacter pylori-infected human gastric mucosa","volume":"165","author":"Luzza","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2014.11.020_b0205","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1084\/jem.20081463","article-title":"Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis","volume":"206","author":"Conti","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.cyto.2014.11.020_b0210","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.chom.2012.04.008","article-title":"Th17 cells in immunity to Candida albicans","volume":"11","author":"Hernandez-Santos","year":"2012","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.cyto.2014.11.020_b0215","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1126\/science.1200439","article-title":"Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity","volume":"332","author":"Puel","year":"2011","journal-title":"Science (New York, NY)"},{"key":"10.1016\/j.cyto.2014.11.020_b0220","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/ACI.0b013e328358cc0b","article-title":"Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis","volume":"12","author":"Puel","year":"2012","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.cyto.2014.11.020_b0225","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1084\/jem.20130877","article-title":"Oral-resident natural Th17 cells and gammadelta T cells control opportunistic Candida albicans infections","volume":"211","author":"Conti","year":"2014","journal-title":"J Exp Med"},{"key":"10.1016\/j.cyto.2014.11.020_b0230","first-page":"635","article-title":"The cup runneth over: lessons from the ever-expanding pool of primary immunodeficiency diseases","volume":"13","author":"Milner","year":"2013","journal-title":"Nat Rev"},{"key":"10.1016\/j.cyto.2014.11.020_b0235","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1128\/IAI.00084-13","article-title":"Clearance of Staphylococcus aureus nasal carriage is T cell dependent and mediated through interleukin-17A expression and neutrophil influx","volume":"81","author":"Archer","year":"2013","journal-title":"Infect Immun"},{"key":"10.1016\/j.cyto.2014.11.020_b0240","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1128\/IAI.01329-06","article-title":"Interleukin-23 (IL-23)-IL-17 cytokine axis in murine pneumocystis carinii infection","volume":"75","author":"Rudner","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.cyto.2014.11.020_b0245","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1365-2567.2010.03280.x","article-title":"Interferon-alpha regulates the dynamic balance between human activated regulatory and effector T cells: implications for antiviral and autoimmune responses","volume":"131","author":"Golding","year":"2010","journal-title":"Immunology"},{"key":"10.1016\/j.cyto.2014.11.020_b0250","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/nyas.12011","article-title":"The life of regulatory T cells","volume":"1283","author":"Gratz","year":"2013","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.cyto.2014.11.020_b0255","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/imr.12173","article-title":"Once a Treg, always a Treg?","volume":"259","author":"Sawant","year":"2014","journal-title":"Immunol Rev"},{"key":"10.1016\/j.cyto.2014.11.020_b0260","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1084\/jem.20030152","article-title":"Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3","volume":"198","author":"Chen","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.cyto.2014.11.020_b0265","doi-asserted-by":"crossref","first-page":"6519","DOI":"10.4049\/jimmunol.172.11.6519","article-title":"Cutting edge: IL-2 is critically required for the in vitro activation of CD4+CD25+ T cell suppressor function","volume":"172","author":"Thornton","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2014.11.020_b0270","doi-asserted-by":"crossref","first-page":"7487","DOI":"10.1158\/0008-5472.CAN-07-0565","article-title":"Interleukin-2 administration alters the CD4+FOXP3+ T-cell pool and tumor trafficking in patients with ovarian carcinoma","volume":"67","author":"Wei","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.cyto.2014.11.020_b0275","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1600-065X.2011.01018.x","article-title":"Regulatory T cells and Foxp3","volume":"241","author":"Rudensky","year":"2011","journal-title":"Immunol Rev"},{"key":"10.1016\/j.cyto.2014.11.020_b0280","doi-asserted-by":"crossref","first-page":"3808","DOI":"10.1093\/jimmunol\/186.7.3808","article-title":"Pillars article: immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases.","volume":"186","author":"Sakaguchi","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2014.11.020_b0285","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.autrev.2011.09.008","article-title":"Regulatory T cells in systemic lupus erythematosus (SLE); role of peptide tolerance","volume":"11","author":"Sawla","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.cyto.2014.11.020_b0290","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.immunol.25.022106.141623","article-title":"Regulatory T cells: mechanisms of differentiation and function","volume":"30","author":"Josefowicz","year":"2012","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.cyto.2014.11.020_b0295","doi-asserted-by":"crossref","first-page":"e86551","DOI":"10.1371\/journal.pone.0086551","article-title":"Role of lymphocyte activation gene-3 (Lag-3) in conventional and regulatory T cell function in allogeneic transplantation","volume":"9","author":"Sega","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cyto.2014.11.020_b0300","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/ni1572","article-title":"The Foxp3+ regulatory T cell: a jack of all trades, master of regulation","volume":"9","author":"Tang","year":"2008","journal-title":"Nat Immunol"},{"key":"10.1016\/j.cyto.2014.11.020_b0305","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1196\/annals.1447.046","article-title":"Immunoregulatory pathways controlling progression of autoimmunity in NOD mice","volume":"1150","author":"You","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.cyto.2014.11.020_b0310","first-page":"480","article-title":"New insights into the regulation of T cells by gamma(c) family cytokines","volume":"9","author":"Rochman","year":"2009","journal-title":"Nat Rev"},{"key":"10.1016\/j.cyto.2014.11.020_b0315","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3389\/fimmu.2012.00191","article-title":"Mechanisms of T(reg) suppression: still a long way to go","volume":"3","author":"Vignali","year":"2012","journal-title":"Front Immunol"},{"key":"10.1016\/j.cyto.2014.11.020_b0320","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.immuni.2004.08.010","article-title":"Role of LAG-3 in regulatory T cells","volume":"21","author":"Huang","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2014.11.020_b0325","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/nature06878","article-title":"TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function","volume":"453","author":"Zhou","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.cyto.2014.11.020_b0330","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1002\/eji.200838331","article-title":"Interleukin 10 suppresses Th17 cytokines secreted by macrophages and T cells","volume":"38","author":"Gu","year":"2008","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.cyto.2014.11.020_b0335","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.imlet.2009.10.006","article-title":"IL-10 suppresses Th17 cells and promotes regulatory T cells in the CD4+ T cell population of rheumatoid arthritis patients","volume":"127","author":"Heo","year":"2010","journal-title":"Immunol Lett"},{"key":"10.1016\/j.cyto.2014.11.020_b0340","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1002\/art.34565","article-title":"Th17 cells are restrained by Treg cells via the inhibition of interleukin-6 in patients with rheumatoid arthritis responding to anti-tumor necrosis factor antibody therapy","volume":"64","author":"McGovern","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cyto.2014.11.020_b0345","doi-asserted-by":"crossref","first-page":"4440","DOI":"10.4049\/jimmunol.1002860","article-title":"Sensitivity and resistance to regulation by IL-4 during Th17 maturation","volume":"187","author":"Cooney","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2014.11.020_b0350","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/ni1375","article-title":"Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells","volume":"7","author":"Batten","year":"2006","journal-title":"Nat Immunol"},{"key":"10.1016\/j.cyto.2014.11.020_b0355","doi-asserted-by":"crossref","first-page":"535361","DOI":"10.1155\/2012\/535361","article-title":"Comprehensive evaluation of different T-helper cell subsets differentiation and function in rheumatoid arthritis","volume":"2012","author":"Chen","year":"2012","journal-title":"J Biomed Biotechnol"},{"key":"10.1016\/j.cyto.2014.11.020_b0360","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s00296-010-1710-0","article-title":"The Th17\/Treg imbalance and cytokine environment in peripheral blood of patients with rheumatoid arthritis","volume":"32","author":"Wang","year":"2012","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.cyto.2014.11.020_b0365","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1007\/s10875-011-9542-6","article-title":"Combined treatment of etanercept and MTX reverses Th1\/Th2, Th17\/Treg imbalance in patients with rheumatoid arthritis","volume":"31","author":"Lina","year":"2011","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.cyto.2014.11.020_b0370","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/art.30093","article-title":"Th17 cells, but not Th1 cells, from patients with early rheumatoid arthritis are potent inducers of matrix metalloproteinases and proinflammatory cytokines upon synovial fibroblast interaction, including autocrine interleukin-17A production","volume":"63","author":"van Hamburg","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cyto.2014.11.020_b0375","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1007\/s00296-011-1984-x","article-title":"Disturbed Th17\/Treg balance in patients with rheumatoid arthritis","volume":"32","author":"Niu","year":"2012","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.cyto.2014.11.020_b0380","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/BOR.0b013e32835d0ee4","article-title":"The effect of autoimmune arthritis treatment strategies on regulatory T-cell dynamics","volume":"25","author":"Mijnheer","year":"2013","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.cyto.2014.11.020_b0385","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1080\/03009740701482800","article-title":"Accumulation of FoxP3-expressing CD4+CD25+ T cells with distinct chemokine receptors in synovial fluid of patients with active rheumatoid arthritis","volume":"36","author":"Jiao","year":"2007","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.cyto.2014.11.020_b0390","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1365-2249.2005.02754.x","article-title":"CD4+ CD25+ T cells with the phenotypic and functional characteristics of regulatory T cells are enriched in the synovial fluid of patients with rheumatoid arthritis","volume":"140","author":"Mottonen","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.cyto.2014.11.020_b0395","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1002\/art.20499","article-title":"CD4(+)CD25(+) regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid","volume":"50","author":"van Amelsfort","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cyto.2014.11.020_b0400","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.autrev.2013.12.004","article-title":"Th17 and regulatory T cell balance in autoimmune and inflammatory diseases","volume":"13","author":"Noack","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.cyto.2014.11.020_b0405","doi-asserted-by":"crossref","first-page":"R97","DOI":"10.1186\/ar4545","article-title":"CD4(+)CD25(+)\/highCD127low\/(\u2212) regulatory T cells are enriched in rheumatoid arthritis and osteoarthritis joints\u2013analysis of frequency and phenotype in synovial membrane, synovial fluid and peripheral blood","volume":"16","author":"Moradi","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.cyto.2014.11.020_b0410","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1136\/ard.2006.068320","article-title":"Imbalance in distribution of functional autologous regulatory T cells in rheumatoid arthritis","volume":"66","author":"Behrens","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cyto.2014.11.020_b0415","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1136\/ard.2008.100768","article-title":"FOXP3 expression in blood, synovial fluid and synovial tissue during inflammatory arthritis and intra-articular corticosteroid treatment","volume":"68","author":"Raghavan","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cyto.2014.11.020_b0420","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nrrheum.2014.96","article-title":"Rheumatoid arthritis: who knows why regulatory T cells are defective in RA \u2026 IDO","volume":"10","author":"Bernard","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.cyto.2014.11.020_b0425","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1002\/eji.201444453","article-title":"A novel upstream enhancer of FOXP3, sensitive to methylation-induced silencing, exhibits dysregulated methylation in rheumatoid arthritis Treg cells","volume":"44","author":"Kennedy","year":"2014","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.cyto.2014.11.020_b0430","doi-asserted-by":"crossref","first-page":"19396","DOI":"10.1073\/pnas.0806855105","article-title":"Defects in CTLA-4 are associated with abnormal regulatory T cell function in rheumatoid arthritis","volume":"105","author":"Flores-Borja","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cyto.2014.11.020_b0435","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1002\/art.38715","article-title":"Treg cell function in rheumatoid arthritis is compromised by ctla-4 promoter methylation resulting in a failure to activate the indoleamine 2,3-dioxygenase pathway","volume":"66","author":"Cribbs","year":"2014","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"key":"10.1016\/j.cyto.2014.11.020_b0440","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/nm.3085","article-title":"Phosphorylation of FOXP3 controls regulatory T cell function and is inhibited by TNF-alpha in rheumatoid arthritis","volume":"19","author":"Nie","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.cyto.2014.11.020_b0445","doi-asserted-by":"crossref","first-page":"e10558","DOI":"10.1371\/journal.pone.0010558","article-title":"Modulation of IL-17 and Foxp3 expression in the prevention of autoimmune arthritis in mice","volume":"5","author":"Duarte","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.cyto.2014.11.020_b0450","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.humimm.2010.01.010","article-title":"IL-21 regulates Th17 cells in rheumatoid arthritis","volume":"71","author":"Niu","year":"2010","journal-title":"Hum Immunol"},{"key":"10.1016\/j.cyto.2014.11.020_b0455","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1002\/art.24126","article-title":"Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses","volume":"58","author":"Fujimoto","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cyto.2014.11.020_b0460","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1002\/art.34477","article-title":"Brief report: inhibition of interleukin-6 function corrects Th17\/Treg cell imbalance in patients with rheumatoid arthritis","volume":"64","author":"Samson","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cyto.2014.11.020_b0465","doi-asserted-by":"crossref","first-page":"R99","DOI":"10.1186\/ar3824","article-title":"Inhibition of Th17 differentiation by anti-TNF-alpha therapy in uveitis patients with Behcet\u2019s disease","volume":"14","author":"Sugita","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.cyto.2014.11.020_b0470","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/nrrheum.2009.183","article-title":"Regulatory T cells as therapeutic targets in rheumatoid arthritis","volume":"5","author":"Esensten","year":"2009","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.cyto.2014.11.020_b0475","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3389\/fonc.2014.00209","article-title":"Utilizing regulatory T cells against rheumatoid arthritis","volume":"4","author":"Haque","year":"2014","journal-title":"Front Oncol"},{"key":"10.1016\/j.cyto.2014.11.020_b0480","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/ni.1882","article-title":"The dual nature of T(H)17 cells: shifting the focus to function","volume":"11","author":"O\u2019Connor","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1016\/j.cyto.2014.11.020_b0485","first-page":"591","article-title":"Modulation of autoimmune diseases by interleukin (IL)-17 producing regulatory T helper (Th17) cells","volume":"138","author":"Singh","year":"2013","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.cyto.2014.11.020_b0490","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.4049\/jimmunol.0802487","article-title":"Anti-inflammatory role of IL-17 in experimental autoimmune uveitis","volume":"182","author":"Ke","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2014.11.020_b0495","doi-asserted-by":"crossref","first-page":"4793","DOI":"10.1073\/pnas.0900408106","article-title":"Identification of IL-17-producing FOXP3+ regulatory T cells in humans","volume":"106","author":"Voo","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cyto.2014.11.020_b0500","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.4049\/jimmunol.1302936","article-title":"Differentiation of IL-17-producing effector and regulatory human T cells from lineage-committed naive precursors","volume":"193","author":"Mercer","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2014.11.020_b0505","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3109\/08916934.2010.517815","article-title":"Anti-IL-17A therapy protects against bone erosion in experimental models of rheumatoid arthritis","volume":"44","author":"Chao","year":"2011","journal-title":"Autoimmunity"},{"key":"10.1016\/j.cyto.2014.11.020_b0510","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/art.20001","article-title":"Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion","volume":"50","author":"Lubberts","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cyto.2014.11.020_b0515","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/art.27334","article-title":"LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double-blind, placebo-controlled, proof-of-concept study","volume":"62","author":"Genovese","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cyto.2014.11.020_b0520","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1315231","article-title":"Brodalumab, an anti-IL17RA monoclonal antibody, in psoriatic arthritis","volume":"370","author":"Mease","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"Suppl 2","key":"10.1016\/j.cyto.2014.11.020_b0525","doi-asserted-by":"crossref","first-page":"iii116","DOI":"10.1136\/annrheumdis-2012-202371","article-title":"Effect of IL-17A blockade with secukinumab in autoimmune diseases","volume":"72","author":"Patel","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cyto.2014.11.020_b0530","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1126\/scitranslmed.3001107","article-title":"Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis","volume":"2","author":"Hueber","year":"2010","journal-title":"Sci Translational Med"},{"key":"10.1016\/j.cyto.2014.11.020_b0535","doi-asserted-by":"crossref","first-page":"R164","DOI":"10.1186\/ar4347","article-title":"A phase Ib multiple ascending dose study evaluating safety, pharmacokinetics, and early clinical response of brodalumab, a human anti-IL-17R antibody, in methotrexate-resistant rheumatoid arthritis","volume":"15","author":"Martin","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.cyto.2014.11.020_b0540","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0140-6736(09)60140-9","article-title":"Ustekinumab, a human interleukin 12\/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial","volume":"373","author":"Gottlieb","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.cyto.2014.11.020_b0545","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S0140-6736(13)60594-2","article-title":"Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial","volume":"382","author":"McInnes","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.cyto.2014.11.020_b0550","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1136\/annrheumdis-2013-204655","volume":"73","author":"Ritchlin","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cyto.2014.11.020_b0555","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/ni.1995","article-title":"Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5","volume":"12","author":"Yang","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/j.cyto.2014.11.020_b0560","doi-asserted-by":"crossref","first-page":"9358","DOI":"10.1074\/jbc.C600321200","article-title":"STAT3 regulates cytokine-mediated generation of inflammatory helper T cells","volume":"282","author":"Yang","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cyto.2014.11.020_b0565","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/art.38305","article-title":"STA-21, a promising STAT-3 inhibitor that reciprocally regulates Th17 and Treg cells, inhibits osteoclastogenesis in mice and humans and alleviates autoimmune inflammation in an experimental model of rheumatoid arthritis","volume":"66","author":"Park","year":"2014","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"key":"10.1016\/j.cyto.2014.11.020_b0570","doi-asserted-by":"crossref","first-page":"e86062","DOI":"10.1371\/journal.pone.0086062","article-title":"EGCG attenuates autoimmune arthritis by inhibition of STAT3 and HIF-1alpha with Th17\/Treg control","volume":"9","author":"Yang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cyto.2014.11.020_b0575","series-title":"Celastrus-derived Celastrol modulates autoimmune arthritis through cellular immunoregulation immunity & tolerance: 78th cold spring harbor symposium on quantitative biology","author":"Astry","year":"2013"},{"key":"10.1016\/j.cyto.2014.11.020_b0580","doi-asserted-by":"crossref","first-page":"e78843","DOI":"10.1371\/journal.pone.0078843","article-title":"Grape seed proanthocyanidin extract-mediated regulation of STAT3 proteins contributes to Treg differentiation and attenuates inflammation in a murine model of obesity-associated arthritis","volume":"8","author":"Jhun","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cyto.2014.11.020_b0585","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1002\/art.38313","article-title":"Halofuginone ameliorates autoimmune arthritis in mice by regulating the balance between Th17 and Treg cells and inhibiting osteoclastogenesis","volume":"66","author":"Park","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.cyto.2014.11.020_b0590","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nature09978","article-title":"Digoxin and its derivatives suppress TH17 cell differentiation by antagonizing RORgammat activity","volume":"472","author":"Huh","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.cyto.2014.11.020_b0595","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/nature10075","article-title":"Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligand","volume":"472","author":"Solt","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.cyto.2014.11.020_b0600","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/ni.1813","article-title":"Structural basis of receptor sharing by interleukin 17 cytokines","volume":"10","author":"Ely","year":"2009","journal-title":"Nat Immunol"},{"key":"10.1016\/j.cyto.2014.11.020_b0605","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.4049\/jimmunol.170.4.2106","article-title":"IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide-induced airway neutrophilia: IL-15 as a possible trigger","volume":"170","author":"Ferretti","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2014.11.020_b0610","first-page":"556","article-title":"Structure and signalling in the IL-17 receptor family","volume":"9","author":"Gaffen","year":"2009","journal-title":"Nat Rev"},{"key":"10.1016\/j.cyto.2014.11.020_b0615","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1067\/mai.2001.117929","article-title":"IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines","volume":"108","author":"Molet","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.cyto.2014.11.020_b0620","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0960-8966(01)00250-4","article-title":"Expression of IL-17B in neurons and evaluation of its possible role in the chromosome 5q-linked form of Charcot\u2013Marie\u2013Tooth disease","volume":"12","author":"Moore","year":"2002","journal-title":"Neuromuscular Disord: NMD"},{"key":"10.1016\/j.cyto.2014.11.020_b0625","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S1359-6101(03)00002-9","article-title":"Interleukin-17 family and IL-17 receptors","volume":"14","author":"Moseley","year":"2003","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.cyto.2014.11.020_b0630","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.4049\/jimmunol.181.6.4299","article-title":"Identification of functional roles for both IL-17RB and IL-17RA in mediating IL-25-induced activities","volume":"181","author":"Rickel","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2014.11.020_b0635","doi-asserted-by":"crossref","first-page":"642","DOI":"10.4049\/jimmunol.169.2.642","article-title":"Cutting edge: IL-17D, a novel member of the IL-17 family, stimulates cytokine production and inhibits hemopoiesis","volume":"169","author":"Starnes","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2014.11.020_b0640","doi-asserted-by":"crossref","first-page":"566","DOI":"10.4049\/jimmunol.177.1.566","article-title":"IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis","volume":"177","author":"Komiyama","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2014.11.020_b0645","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cellimm.2005.11.002","article-title":"Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis","volume":"237","author":"Hofstetter","year":"2005","journal-title":"Cell Immunol"},{"key":"10.1016\/j.cyto.2014.11.020_b0650","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2353\/ajpath.2008.070690","article-title":"Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis","volume":"172","author":"Tzartos","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cyto.2014.11.020_b0655","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10875-009-9365-x","article-title":"Plasma IL-17A is increased in new-onset SLE patients and associated with disease activity","volume":"30","author":"Chen","year":"2010","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.cyto.2014.11.020_b0660","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/ni1552","article-title":"Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice","volume":"9","author":"Hsu","year":"2008","journal-title":"Nat Immunol"},{"key":"10.1016\/j.cyto.2014.11.020_b0665","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/jid.2009.59","article-title":"The IL-23\/Th17 axis in the immunopathogenesis of psoriasis","volume":"129","author":"Di Cesare","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.cyto.2014.11.020_b0670","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/sj.jid.5701213","article-title":"Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells","volume":"128","author":"Lowes","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.cyto.2014.11.020_b0675","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1084\/jem.20071094","article-title":"Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses","volume":"204","author":"Zaba","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.cyto.2014.11.020_b0680","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1600-065X.2008.00705.x","article-title":"The interleukin-23 axis in intestinal inflammation","volume":"226","author":"Ahern","year":"2008","journal-title":"Immunol Rev"},{"key":"10.1016\/j.cyto.2014.11.020_b0685","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1084\/jem.20071978","article-title":"Regulation of inflammatory responses by IL-17F","volume":"205","author":"Yang","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.cyto.2014.11.020_b0690","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1172\/JCI21404","article-title":"IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6","volume":"116","author":"Yen","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cyto.2014.11.020_b0695","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/s00125-013-3135-2","article-title":"IL-17A increases the expression of proinflammatory chemokines in human pancreatic islets","volume":"57","author":"Grieco","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/j.cyto.2014.11.020_b0700","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.cellimm.2012.11.001","article-title":"Th17 cells in type 1 diabetes","volume":"280","author":"Shao","year":"2012","journal-title":"Cell Immunol"},{"key":"10.1016\/j.cyto.2014.11.020_b0705","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2174\/1871528110908050383","article-title":"Role of interleukin-17F in asthma","volume":"8","author":"Kawaguchi","year":"2009","journal-title":"Inflamm Allergy Drug Targets"},{"key":"10.1016\/j.cyto.2014.11.020_b0710","doi-asserted-by":"crossref","first-page":"602846","DOI":"10.1155\/2014\/602846","article-title":"Potential involvement of IL-17F in asthma","volume":"2014","author":"Ota","year":"2014","journal-title":"J Immunol Res"},{"key":"10.1016\/j.cyto.2014.11.020_b0715","doi-asserted-by":"crossref","DOI":"10.1189\/jlb.0913482","article-title":"IL-17E (IL-25) and IL-17RB promote respiratory syncytial virus-induced pulmonary disease","author":"Petersen","year":"2014","journal-title":"J leukocyte Biol"},{"key":"10.1016\/j.cyto.2014.11.020_b0720","doi-asserted-by":"crossref","first-page":"5453","DOI":"10.4049\/jimmunol.1001153","article-title":"IL-23 and IL-17A, but not IL-12 and IL-22, are required for optimal skin host defense against Candida albicans","volume":"185","author":"Kagami","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2014.11.020_b0725","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/ni1449","article-title":"IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge","volume":"8","author":"Khader","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.cyto.2014.11.020_b0730","doi-asserted-by":"crossref","first-page":"7980","DOI":"10.4049\/jimmunol.177.11.7980","article-title":"TLR4 mediates vaccine-induced protective cellular immunity to Bordetella pertussis: role of IL-17-producing T cells","volume":"177","author":"Higgins","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2014.11.020_b0735","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nm1710","article-title":"IL-22 mediates mucosal host defense against gram-negative bacterial pneumonia","volume":"14","author":"Aujla","year":"2008","journal-title":"Nat Med"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466614006036?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466614006036?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T21:46:36Z","timestamp":1747431996000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466614006036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":147,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S1043466614006036"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2014.11.020","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Involvement of the IL-23\/IL-17 axis and the Th17\/Treg balance in the pathogenesis and control of autoimmune arthritis","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2014.11.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}